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Abstract
Background: In traditional models of essential tremor, the inferior olivary nucleus was posited to play a central role
as the pacemaker for the tremor. However, recent data call this disease model into question.
Case presentation: Our patient had progressive, long-standing, familial essential tremor. Upper limb tremor
began at age 10 and worsened over time. It continued to worsen during the nine-year period he was
enrolled in our brain donation program (age 85 – 94 years), during which time the tremor moved from the
moderate to severe range on examination. On postmortem examination at age 94, there were degenerative
changes in the cerebellar cortex, as have been described in the essential tremor literature. Additionally, there
was marked degeneration of the inferior olivary nucleus, which was presumed to be of more recent onset.
Such degeneration has not been previously described in essential tremor postmortems. Despite the presence
of this degeneration, the patient’s tremor not only persisted but it continued to worsen during the final
decade of his life.
Conclusions: Although the pathophysiology of essential tremor is not completely understood, evidence such
as this suggests that the inferior olivary nucleus does not play a critical role in the generation of tremor in
these patients.
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Background
Essential tremor (ET) is one of the most common
movement disorders and it is the most common
tremor disorder of humans [1, 2]. Despite its high
prevalence, disease mechanisms are not completely
understood [3, 4]. In recent years, clinical [5–9] and
neuroimaging [3, 10–12] studies suggest that the
cerebellum plays an important role in the generation
of tremor in ET. Furthermore, a constellation of
pathological changes is present in the ET cerebellum,
mainly in the cerebellar cortex and involving the
Purkinje cell and its neighboring neuronal populations,
and distinguishes ET from control brains. These findings
further support the central role that the cerebellum plays
in ET pathogenesis [13–17].
It is clear that the cerebellum is of mechanistic im-
portance in ET. The disease is likely the result of an
abnormal motor loop or motor network that origi-
nates in the cerebellar cortex and then in a down-
stream fashion involves the deep cerebellar nuclei, the
motor nuclei of the thalamus and motor cerebral cor-
tex (i.e., an abnormal cerebellar-thalamic-cortical
loop). In older models of ET, the inferior olivary
nucleus (ION) was also included, and it was this
structure that was posited to drive the tremor. How-
ever, this older model has fallen out of favor [18, 19]
for a number of reasons, including the normal ap-
pearance of the ION on most neuroimaging studies
[3, 20–22] as well as on postmortem comparisons of
ET and control brains [23].
Recently, Elkouzi and colleagues [24] reported a pa-
tient with longstanding ET who developed hypertrophic
olivary degeneration later in life, characterized clinically
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by ataxia and palatal tremor and by olivary pseudo-
hypertrophy on magnetic resonance imaging. His ET
tremor did not lessen despite the onset of this second
syndrome of olivary degeneration and, based on this ob-
servation, the authors concluded that the ION was not
the source of tremor in their patient [24]. We now
report a case with longstanding, severe familial ET.
Postmortem examination revealed marked olivary de-
generation in addition to cerebellar degenerative
changes. Despite this olivary degeneration, the patient’s
tremor had continued to worsen, rather than disappear-
ing, during the last decade of life.
Case presentation
Clinical history
At age 85 years, a right-handed Caucasian man with
a Master’s degree enrolled in the Essential Tremor
Centralized Brain Repository, a joint effort between
investigators at Yale and Columbia Universities [25,
26]. Upon enrollment, the patient signed a written
informed consent form, which was approved by both
the Yale and Columbia University ethics committees.
He reported that tremor had begun at 10 years of
age. There was a family history of tremor in two
first-degree relatives - both his mother and brother
had had tremor. He reported that he had never been
exposed to medications with known cerebellar tox-
icity (e.g., diphenylhydantoin, cytosine arabinoside)
nor had he been a heavy drinker of ethanol (as de-
fined previously) [14, 27] at any point in time. He
had been diagnosed with ET by a neurologist “many
years” prior to enrollment. He had taken medications
for the tremor at some point long before enrollment
but had discontinued them and could not recall their
names. His past medical history was otherwise not-
able for arthritis, diverticula, high blood pressure, an
enlarged prostate and need for a hearing aid.
Recently, he had required a cane to walk.
Upon enrollment, he reported that the tremor af-
fected his arms rather than his head, jaw or voice
and that it impaired his ability to perform many of
his activities of daily living (e.g., carrying a cup of
water or coffee, drinking from a glass, using a spoon
to eat soup, and cutting, trimming and filing his fin-
ger nails). He declined a detailed videotape neuro-
logical examination at that time.
Three years after enrollment, at age 88, a detailed
videotaped neurological examination was first per-
formed and tremor was rated by one of the authors
(E.D.L.), a senior movement disorders neurologist,
from 0 to 3, as described [14, 28]. There was no
tremor at rest. Right arm/left arm tremor ratings were
as follows, respectively: 2/1.5 (arm extension), 3/1.5
(pouring water between two cups), 2/2 (finger-nose-
finger maneuver), and 3/2 (drawing Archimedes spi-
rals). During finger-nose-finger maneuver intention
tremor was not visualized. Tremor was not visualized
in the neck, voice, or jaw. Palatal tremor was not
evident. There was no dysarthria or dysmetria of
hand movements. There was mild dysmetria on the
heel-shin test on both sides (Scale for the Assessment
and Rating of Ataxia score = 1) [29]. There was no
hypomimia, hypophonia, or reduction in arm swing,
and Unified Parkinson’s disease Rating Scale [30]
scores on finger taps, opening and closing fists, and
wrist pronation-supination were in the 0 – 1 range in
both arms. There was no dystonia. Motor timing
disturbances were not evaluated. The gait was mea-
sured, cautious and slow but not ataxic; it was
assisted with a cane. Because of the cane, the patient was
reluctant to attempt tandem gait. Based on this history
and examination, a Washington Heights Inwood Genetic
Study of ET diagnosis of definite ET [31] was assigned.
During follow-up, his Archimedes spirals continued to
show considerable tremor, which worsened over time -
right/left ratings of 2/2 (age 85) evolved to 3/3 (age 93
[8.5 months prior to death]) (Fig. 1). Detailed discussions
with his family indicated that the severe arm tremor per-
sisted to the time of death at age 94.
A Folstein mini-mental state [32] score was 30/30 at
age 88. A telephone interview for cognitive status [33]
score was 32 /41 (age 89) and 29/41 (age 90). He died at
age 94.
Postmortem methods
As described [16, 34], the brain had a complete neuropatho-
logical assessment at the Essential Tremor Centralized Brain
Repository in the New York Brain Bank and had standard-
ized measurements of brain weight (grams) and postmortem
interval (PMI, hours between death and placement of brain
in a cold room or upon ice). Blocks were taken from stan-
dardized brain regions and embedded in paraffin; 7 μm-thick
sections were stained with Luxol fast blue counterstained
with hematoxylin-eosin (LH&E). Additional sections from
selected blocks were stained with modified Bielschowsky
silver stain, and others, with antibodies directed against α-sy-
nuclein (1:40, Leica, Buffalo Grove, IL, USA) (including cere-
bral cortex, cingulate gyrus, hippocampal formation, globus
pallidum, putamen, amygdala, subthalamic nucleus, mid-
brain with substantia nigra, pons with the locus ceruleus,
and medulla with the dorsal vagal nucleus), β-amyloid
(1:400, Biocare Medical, Concord, CA, USA), and hyperpho-
sphorylated tau (AT8) (1:200, Thermoscientific, Rockford, IL,
USA), performed in an automated immunostainer (Ventana,
Benchmark Ultra, Tuscon, AZ). Braak and Braak AD staging
for neurofibrillary tangles [35, 36] and the Consortium to
Establish a Registry for AD (CERAD) ratings for neuritic pla-
ques [37] were assigned.
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A standard 3 × 20 × 25 mm parasagittal, formalin-fixed,
tissue block was harvested from the neocerebellum; this
block included cortex, white matter and dentate nucleus
[25, 26]. A senior neuropathologist (P.L.F.), blinded to
clinical information, counted torpedoes in one entire
LH&E section and another entire Bielschowsky-stained
section [16] from that block. The neuropathologist
counted heterotopic Purkinje cells (i.e., a Purkinje cell
whose cell body was completely surrounded by the mo-
lecular layer and that did not contact the granule layer) in
the entire LH&E stained section.
Purkinje cells in 15 randomly-selected 100× LH&E
stained fields of the standard cerebellar section were
counted. The average of these 15 counts was reported as
the mean number of Purkinje cells per 100× field.
A semi-quantitative rating of the appearance of the basket
cell plexus surrounding Purkinje cell bodies throughout the
Bielschowsky preparation, described above, was applied using
the following scale: 0 (few or no discernible processes); 1
(sparse number of processes); 2 (moderate number of pro-
cesses); and 3 (dense tangle of processes), as described [17].
The density of neurons in the principal ION was
quantified, counting only those neurons with an
identifiable nucleolus in order to provide a point-like
cell identifier. The total number of neurons with
nucleoli was normalized to a traced linear length of
the ION nucleus (in microns), measured with Neu-
rolucida software (MicroBrightField Bioscience, Will-
iston, VT). This was used to create an index of ION
linear density (neurons/length in microns × 1000).
CalbindinD28k immunohistochemistry was performed
in free-floating 100 μm thick, formalin-fixed vibratome
sections of cerebellar cortex to visualize Purkinje cell
axonal morphology as described previously [14]. Pur-
kinje cell axonal morphology in 10 randomly-selected
100× images was quantified: thickened Purkinje cell
axonal profiles (an axon with at least double the width
of other apparently normal axons), Purkinje cell axonal
branching (any Purkinje cell axon with at least one
branch point; multiple bifurcations on the same axon
were not separately counted), and Purkinje cell axonal
recurrent collaterals (an axon with at least a 90° turn
back towards the Purkinje cell layer from its initial tra-
jectory) [14]. Arciform axons were Purkinje cell axons
that were more gradually curving back towards the
Purkinje cell layer with a changing trajectory that was
<90° [14]. Terminal axonal sprouting was the presence
of a frayed terminal axonal region, often with a kinky ap-
pearance [14]. The raw counts of Purkinje cell axonal
features were normalized to the total length of the
Purkinje cell layer length (in microns) [14, 25, 26].
Seven μm thick paraffin-embedded sections of cerebel-
lum and medulla were incubated with polyclonal rabbit
anti-calbindinD28k (1:1000, Swant Inc., Marly, Switzerland)
or mouse monoclonal glutamatic acid decarboxylase
(GAD) (1:100, MBL International, Woburn, MA) at 4 °C
overnight after antigen retrieval in Trilogy (Cell Marque)
in a vegetable steamer for 40 min, 100 °C. The sections
were subsequently incubated with biotinylated anti-rabbit
or anti-mouse IgG (1:200, Vector Labs, Burlingame, CA),
and the signals were amplified by avidin/biotinylated com-
plex with diaminobenzidine staining (Vector Labs).
Postmortem findings
The brain, which weighed 1028.9 g, was placed on ice
3 h after death. External examination (J.P.G.V.) revealed
mild to moderate cerebral cortical atrophy, mild amyg-
dala atrophy, and moderate volume loss of the hippo-
campal formation. There was moderate to severe
atrophy in the cerebellar vermis bilaterally, involving the
entire superior vermis as well as the nodulus but with
preservation of the remaining inferior vermis. Mild to
moderate cerebellar cortical folial atrophy was evident
bilaterally in the neocerebellum, variably involving both
Fig. 1 The patient’s Archimedes spirals (right arm), worsened over time - tremor rating = 2 (moderate) at age 85 (left panel) and tremor rating = 3
(severe) at age 93, which was 8.5 months prior to death (right panel)
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anterior and posterior lobes. The cerebellar dentate nu-
cleus was grossly unremarkable. The remainder of the
brain was grossly unremarkable.
On microscopic examination (J.P.G.V.), there were
Alzheimer’s disease neuropathological changes, with paren-
chymal amyloid burden of deposits = A2, Braak & Braak
stage for neurofibrillary tangles of Alzheimer = IV/VI (i.e.,
B2) and CERAD score for neuritic plaques = C1. Otherwise,
the striatum, thalamus, and red nucleus were normal. On
alpha synuclein immunostain, one 100× microscopic field
of the basal region of the amygdala included five Lewy
bodies but otherwise Lewy body containing neurons were
rare in the amygdala. No Lewy body containing neurons
were found elsewhere; that is, they were not found in the
substantia innominata, substantia nigra pars compacta,
locus ceruleus, or dorsal vagal nucleus on alpha synuclein
immunostain.
The cerebellar cortex was characterized by a range of
degenerative changes (Fig. 2), as have been described in
patients with ET. Purkinje cell loss was marked, and ac-
companied by marked or focally severe Bergmann gliosis
(Fig. 2a-c; Table 1). The molecular layer was thinner
than normal. The loss of granular neurons was patchy,
with a tendency to more severely affect the tips of folia
than their depths. There was an increase in torpedoes
on both LH&E and Bielschowsky-stained sections and
marked hypertrophy of basket cell axonal processes
along with areas where basket cell processes were absent
(Fig. 2c-f; Table 1). An abundance of several other
Purkinje cell axonal changes was identified by calbin-
dinD28k immunohistochemistry (esp. axonal branching
and axonal recurrent collaterals; Fig. 2g-i, Table 1), as
well as an increase in Purkinje cell dendritic swellings
on LH&E and Bielschowsky-stained sections (Table 1).
The myelin stain of the amiculum and hilus of the
dentate nucleus was weaker than normal; in contrast,
the myelin stain of the adjacent album cerebelli was
relatively spared (Fig, 3a and b). The neuronal density
of the dentate nucleus was normal (Fig. 3c and d;
Table 1); however, the soma of these neurons was
atrophic. The normal dense synaptic staining of den-
tate by GAD antibodies that labels predominantly
GABA-ergic Purkinje cell afferents, including distinct
puncta around large GAD-negative neurons (Fig. 3e;
carets in lower panel), was markedly reduced in the
patient’s dentate (Fig. 3f ), consistent with the marked
loss of Purkinje cells; occasional perineuronal puncta
were enlarged in size (Fig. 3f, lower panel, small
Fig. 2 Degenerative changes in the patient’s cerebellar cortex (b, c, e, f, h, i) compared with a control (a, d, g) with LH&E stain (a-c), Bielschowsky
stain (d-f) and calbindinD28k immunostain (g-i). The molecular layer is thinner (b) and there is marked Purkinje cell loss with scattered, often
atrophic Purkinje cells (b, c, white arrows) and Bergmann gliosis (b, c). Basket cell processes are coarse (e, yellow arrows), often around extant or
atrophic (f, white arrow) Purkinje cells, and basket cell processes may be largely absent (e, yellow bars). Compared with control Purkinje cells (g),
the patient’s Purkinje cell dendritic arbors are often stunted (h, i) and axonal changes including torpedoes (c, f, h, i, large black arrows), axonal
branching (H, small black arrows) and recurrent collaterals (h, i, carets) are increased. Scale bars: 100 μm, A, B, D, E; 50 μm, C, F; 100 μm, G-H
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arrowhead), suggesting synaptic degeneration. GAD+
GABA-ergic neurons in the dentate, which project to
the inferior olive [38, 39], were readily detected in
the patient’s dentate (Fig. 3e and f, arrows). As some
of the GAD+ axons still seen in the patient’s dentate
may be from processes of neurons intrinsic to the
dentate, immunostain to calbindinD28k was also per-
formed, further demonstrating marked synaptic loss
from Purkinje cells and only scattered degenerate
and/or sprouting axonal profiles in the patient’s den-
tate (Fig. 3g and h).
Olivary degeneration was marked (Fig. 4a-d) and bilat-
eral. The dorsal and ventral arms of the principal olive
show marked and uneven neuronal loss, highlighted by
immunostain to calbindinD28k (Fig. 4e–j). The residual
olivary neurons were atrophic (Fig. 4d, small black
arrows) and surrounded by gliotic parenchyma. Quanti-
fication of ION neuronal linear density revealed marked
neuronal loss, being only ~25% of the values previously
determined in ET cases and controls (Table 1), and
consistent with myelin pallor in LH&E stain and loss of
calbindinD28k labeled olivo-cerebellar fibers in the hilum
of the principal olive (Fig. 4b and f). In contrast to the
principal olive, neurons in the medial accessory olive
(black arrows in Fig. 4a–f ) and a medial segment in the
ventral arm of the principal olive were preserved (Fig. 4f).
The reciprocal nucleo-olivary innervation from GAD+
GABA-ergic neurons in cerebellar nuclei was relatively
well preserved in the patient’s olivary nuclei, although
there was some irregular patchy synaptic loss more prom-
inent in parts of the dorsal arm and lateral bend of the
principal olive at this medullary level (Fig. 4g and h),
Table 1 Postmortem cerebellar changes in our patient
Measure Data from
current casea
Contextual comments (i.e., published comparative data)
Cerebellar Cortex
Torpedoes (LH&E) 17 In a prior publication [16], the mean value in ET cases = 10.5 ± 8.0 and in
controls = 1.7 ± 1.4. None of the 21 controls had a value >5.
Torpedoes (Bielschowsky) 19 In a prior publication [16], the mean value in ET cases = 16.5 ± 14.2 and in
controls = 3.3 ± 7.3.
Axonal changes (calbindinD28k) In a prior publication [14]:
Thickened axonal profiles 1.2 (0.8) 0.6 ± 0.7 (cases) vs. 0.4 ± 0.6 (controls)
Axonal branching 10.8 (7.5) 0.3 ± 0.4 (cases) vs. 0.1 ± 0.2 (controls)
Axonal recurrent collaterals 16.8 (11.7) 1.0 ± 0.8 (cases) vs. 0.4 ± 0.5 (controls)
Arciform axons 0.10 (0.07) 0.08 ± 0.11 (cases) vs. 0.04 ± 0.07 (controls)
Terminal axonal sprouting 0.13 (0.09) 0.19 ± 0.22 (cases) vs. 0.07 ± 0.14 (controls)
Dendritic swellings (LH&E) 3 In a prior publication [44], the mean value in 20 ET cases = 1.50 ± 1.79 and in
19 controls = 0.05 ± 0.23. None of the 19 controls had >1 dendritic swelling.
Dendritic swellings (Bielschowsky) 3.5 In a prior publication [44], the mean value in 20 ET cases = 2.70 ± 3.10 and in
19 controls = 0.37 ± 0.50. None of the 19 controls had >1 dendritic swelling.
Purkinje cell count (LH&E, 15 100× fields) 0.8 In a prior publication [16], the mean value in ET cases = 7.2 ± 2.6 and in
controls = 9.6 ± 3.4. None of the 33 ET cases or 21 controls had values as
low as 0.8.
Heterotopic Purkinje cells (LH&E) 1.5 In a prior publication [46], the median number in 35 ET cases = 3 and in
32 controls = 1.
Basket rating (Bielschowsky) 3 In a prior publication [17], 8/37 (21.6%) ET cases and 3/69 (4.3%) controls
had this value.
ION
ION neuronal linear density (LH&E),
neurons/μm × 1000
2.3 In a prior publication [23], the mean value in 14 ET cases = 9.4 ± 3.2 and in
15 controls = 8.8 ± 3.1.
Dentate Nucleus
Dentate dorsal neuronal density,
LH&E), neurons/μm2 × 10−5
1.95 In a prior publication [55], the mean value in 25 ET cases = 1.5 ± 0.5 and in
25 controls = 1.5 ± 0.4.
Dentate ventral neuronal density
(LH&E), neurons/μm2 × 10−5
1.7 In a prior publication [55], the mean value in 25 ET cases = 1.5 ± 0.5 and in
25 controls = 1.4 ± 0.5.
Dentate total neuronal density, (LH&E),
neurons/μm2 × 10−5
1.8 In a prior publication [55], the mean value in 25 ET cases = 1.5 ± 0.4 and in
25 controls = 1.4 ± 0.5.
ET Essential tremor, ION Inferior olivary nucleus, LH&E Luxol fast blue counterstained with hematoxylin-eosin
aValues are mean (median)
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indicating some loss of these neurons in regions of the
dentate nucleus.
In the dorsal arm of the principal olive in this patient,
there was a region with somewhat greater preservation,
seen in both calbindinD28k and GAD immunostains
(Fig. 4f–h, red arrows). In an adjacent more rostral
level of the medulla, this region of relative neuronal
preservation was even more striking, and present bi-
laterally (Fig. 5a-d, red arrows). Loss of GAD+
GABA-ergic nucleo-olivary afferents was more prom-
inent in this section, particularly involving lateral and
ventral regions of the principal olive (Fig. 5c and d).
Discussion and conclusions
Our patient had ET that was (1) of longstanding dur-
ation (i.e., from age 10 to death at age 94), (2) of
childhood-onset (beginning at age 10), (3) clinically-
progressive until death (Fig. 1), and (4) familial (i.e., by
the patient’s report, two first-degree relatives were also
affected). The features of the action tremor were typical
of ET, with kinetic tremor greater than postural tremor
[40] and there were no accompanying clinical features of
parkinsonism or dystonia.
This case is similar in some respects to that
reported by Elkouzi and colleagues [24]. Their patient
had longstanding ET and then in later life developed
degeneration of the ION. Despite this, their patient’s
tremor did not change. The two cases differ in the
sense that the types of changes in the ION were not
the same – the published cases had pseudo-
hypertrophic olivary degeneration [24] and ours had
olivary degeneration of indeterminate cause. Also, our
case came to postmortem, whereas the olivary
changes in the published case were noted on brain
imaging alone [24]. As discussed by Elkouzi and
colleagues [24], these cases argue against the ION
hypothesis of ET. The tremor in their case stayed the
same after the onset of olivary degeneration. In our
case, the age of onset of olivary degeneration is not
known, but regardless, the tremor was documented to
worsen, even during the final years of life, during
which time, olivary degeneration must have been
present (Fig. 1).
In postmortem studies of ET cases and controls,
changes in the ION have not been detected [16, 41].
Moreover, in a detailed postmortem study of 14 ET
cases and controls, a series of metrics was used to
quantify microscopic neuronal and glial changes in
the ION and its input and output tracts [23]. ION
linear neuronal density also was assessed [23]. Cases
and controls did not differ from one another with
respect to any of the assessed metrics, and linear
neuronal density also was similar in both groups [23].
In another study, the authors used vesicular glutamate
transporter type 2 immunohistochemistry to label
climbing fiber-Purkinje cell synapses in 12 ET cases
and 13 controls [42]. Compared to controls, ET cases
had decreased climbing fiber-Purkinje cell synaptic
density, more climbing fibers extending to the outer
portion of the molecular layer, and more climbing
fiber-Purkinje cell synapses on the thin Purkinje cell
spiny branchlets [42]. The interpretation of these
findings is unclear. One possibility is that the abnor-
mal climbing fiber-Purkinje cell synaptic connections
in ET could be secondary to Purkinje cell degener-
ation while another is that it is due to a primary
process involving the ION itself [42].
Fig. 3 Degenerative changes in the patient’s dentate nucleus (b, d, f, h)
compared with a control (a, c, e, g) with LH&E stain (a-d), GAD
immunostain (e-f) and calbindinD28k immunostain (g-h). a, b Myelin pallor
in the patient’s amiculum (a) and hilum (h) of the dentate nucleus. c, d
Dentate neuronal density is normal, although the soma of these neurons
was often atrophic (d). Marked reduction of afferent synaptic density from
Purkinje cells in dentate demonstrated by GAD (e, f) and calbinidinD28k
immunostain (g, h). GAD+−synaptic puncta around large GAD-negative
dentate neurons (e, carets in bottom panel) are reduced (f), and some
residual synaptic puncta are enlarged (F, small black arrow in bottom
panel). GAD+−dentate neurons (e, f, black arrows) are readily identified.
Degeneration and/or sprouting of residual Purkinje cell axons is evident
(h, small black arrows and inset). There is artifactual staining of atrophic
dentate neurons (h). Scale bars: 500 μm, A, B; 100 μm, C, D, and E, F
(top panel), G, H. 50 μm, E, F (bottom panel), H, inset
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The cerebellar cortex was characterized by a range of
degenerative changes (Fig. 2, Table 1), as have been de-
scribed in patients with ET – an increase in torpedoes
[16, 43] and an abundance of numerous other Purkinje
cell axonal changes (e.g., increased axonal branching and
axonal recurrent collaterals) [14], an increase in Purkinje
cell dendritic swellings [44] and heterotopic Purkinje
cells [45, 46], and marked hypertrophy of basket cell
axonal processes [17]. These changes were within the
range of what has been reported in patients with ET
Fig. 4 Degenerative changes in the patient’s ION (b, d, f, h, j) compared with a control (a, c, e, g, i) with LH&E stain (a-d), calbindinD28k immunostain (e, f, i, j)
and GAD immunostain (g, h). Marked patchy neuronal loss in the patient’s principal olive (b, d, f, j), with myelin pallor and loss of calbindinD28k-labeled olivary
efferents in the hilum (b, f). Residual neurons in the principal olive are often atrophic (small black arrows, d). Olivary neurons and GAD+ nucleo-olivary staining
are preserved in the medial accessory olive (black arrow in a, b, e, f, g, h). GABA-ergic nucleo-olivary afferents show some mild patchy loss predominantly in
dorsal and lateral regions of the principal olive (h). The dorsal arm in the principal olive shows a region with more numerous calbindinD28k-labeled neurons
and preserved GAD staining (red arrow, f, h, j). Scale bars: 250 μm, A, B, E, F, G, H; 200 μm, top panel in C and D, I, J; 50 μm, bottom panel in C and D
Fig. 5 Degenerative changes in the patient’s left (a, c) and right (b, d) ION at a more rostral level, with immunostains to calbindinD28k (a, b) and
GAD (c, d). A distinct region with more numerous calbindinD28k-labeled neurons is again seen in the dorsal arm of the principal olive bilaterally
along with preserved GAD staining (red arrows). There is patchy loss of GAD staining, more prominent in lateral and ventral regions of the
principal olive in this region of ION. Scale bar: 250 μm, A-D
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(Table 1). Additionally, there was marked Purkinje cell
loss that was more severe than typically reported in
patients with ET, as well as morphologic changes in the
dentate nucleus largely reflecting loss of Purkinje cell
afferents, only reported to some extent in two prior ET
cases [16], indicating that the degree of degeneration in
the cerebellum in this patient was in some respects even
greater than that seen in ET. In cerebello-olivary
degenerations, degenerative changes in the olive are
presumed to be secondary to retrograde degeneration
due to loss of Purkinje cell targets, and appear to
directly correlate with disease duration [47, 48], although
direct contribution from olivary climbing fibers to
Purkinje cell degeneration cannot be fully excluded.
Our case did not exhibit intention tremor during the
finger-nose-finger maneuver and there was no dysarthria
or dysmetria of hand movements. There was mild dys-
metria on the knee-tibia test on both sides. Mild prob-
lems with limb coordination and even frank ataxia have
been reported in ET [6, 49, 50].
The cerebellum is organized in modules defined by
1) distinct parasagittal Purkinje cell zones projecting
to defined cerebellar or vestibular nucleus regions, 2)
the climbing fiber input from a subdivision of the
contralateral inferior olive with a collateral projection
to the same cerebellar target nucleus region, and 3)
reciprocal connections of this target nucleus with the
contralateral inferior olive by GABA-ergic nucleo-
olivary neurons [38, 51]. The morphologic findings in
this patient demonstrate interesting regional patterns
of neuronal loss in cerebellum and inferior olive that
correlate with this modular organization. The pre-
served Purkinje cells in the inferior vermis (not
shown) and ION neurons in the medial accessory
olive and a medial segment of the ventral principal
olive in this patient (Fig. 4f ) correlate with the soma-
totopic relationship between these areas [38, 52].
Consistent neuronal loss in dorsomedial regions of
ION (Figs. 4 and 5) correlates with marked gross at-
rophy and neuronal loss in superior vermis in this
patient, with similar Purkinje cell and granule cell
loss as demonstrated for motor cerebellum (data not
shown). There was also gross atrophy in lateral
cerebellum of the posterior lobe, correlating with
neuronal loss in lateral and ventral regions of the
principal olive. The region in the dorsal principal
olive with both less neuronal loss and preserved
GABA-ergic nucleo-olivary input (Figs. 4 and 5, red
arrows) is somatotopically connected with anterior
lobe and adjacent posterior quadrangulate lobule in
humans, suggesting there is a cerebellar module with
relatively more intact circuitry, and likely less severe
Purkinje cell loss, involving a region of motor
cerebellum. Last, intact GABA-ergic nucleo-olivary
synaptic staining did not always clearly correlate with
the degree of ION neuronal preservation. Thus, parts
of the circuitry in cerebellar modules may variably
persist and/or be lost, and integrity of ION neurons
appears to more prominently depend on preservation
of olivary climbing fiber connections with Purkinje
cells; a proposed trophic role of GABA-ergic afferents
for survival of ION neurons could potentially contrib-
ute [53, 54].
The patient also had incidental Lewy bodies. On alpha
synuclein stain, one 100× microscopic field of the basal
region of the amygdala included five Lewy bodies but
otherwise Lewy body containing neurons were rare in
the amygdala and not found in the substantia innomi-
nata, substantia nigra pars compacta, locus ceruleus, or
elsewhere on alpha synuclein stain.
The current case study should be interpreted within
the context of several limitations. First, as with any case
study, this was an n of 1. Additional cases are needed to
confirm and elaborate upon our data. Second, we do not
know exactly when the changes in the ION began in our
case. There was no obvious clinical correlate (e.g., myo-
clonus or ataxia); presumably, though, it was a later-life
occurrence.
In summary, although the pathophysiology of ET is
not completely understood, evidence such as this
suggests that the ION does not play a critical role in the
generation of tremor in ET patients.
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